The Biotech Company That's Training Immune Cells To Fight Cancer

Photo by National Cancer Institute on Unsplash

Dr. Henry Ji, President and CEO of Sorrento Therapeutics SRNE, was a guest speaker at Benzinga’s All Access on March 25, 2022. 

Sorrento Therapeutics is a biotechnology company researching and developing innovative solutions to diseases like cancer, intractable pain and COVID-19.

Watch the full interview here:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!